ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Anti-PD1 antibody pucotenlimab in combination with bevacizumab or lenvatinib in a phase II study for the treatment of advanced hepatocellular carcinoma (aHCC).

Zhao, Hong; Zhou, Aiping; Tu, Jianfei; Bai, Yuxian; Mao, Xianhai; Song, Tianqiang; Li, Bo; Dai, Wenxiang; Lv, Jing; Wang, Jufeng; Che, Xu; Liu, Lianxin; Zhang, Lianhai; Wu, Wei; Cai, Jianqiang青岛大学; 哈尔滨医科大学; 中国医科大学; 中国医学科学院; 中国医学科学院北京协和医院; 1
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)2023-6-1
6阅读
引用收藏
分享
相关
加载中…
  • The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma: A phase Ib/II clinical trial
    Bai, L.; Bai, Y.; Huang, M.; Shao, G.; Song, L.; Sun, M.; Wang, W.; Wu, J.; Xu, A.; Huang, L.; Liu, T.; Liu, W.; Wang, Z. M.; Li, B.; Xia, Y.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
  • Tebotelimab, a PD-1/LAG-3 bispecific antibody, in patients with advanced hepatocellular carcinoma who had failed prior targeted therapy and/or immunotherapy: An open-label, single-arm, phase 1/2 dose-escalation and expansion study.
    Ren, Zhenggang; Guo, Yabing; Bai, Yuxian; Ying, Jieer; Meng, Zhiqiang; Chen, Zhendong; Gu, Shanzhi; Zhang, Jingdong; Liang, Jun; Hou, Xinfang; Li, Wei; Xu, Aibing; Hao, Chunyi; Zhang, Jian; Xing, Ruijun; Zhang, Xinyu; Zhang, Dan; Chan, Stephen LamGenitourinary Cancers Symposium, San Francisco, CA, 2023-01-19 To 2023-01-21.被引 3
  • Donafenib combined with anti-PD-1 antibodies plus transarterial therapy for initially unresectable hepatocellular carcinoma
    Wen, Yaohong; Fu, Shunjun; He, Guolin; Cai, Lei; Liu, Yahong; Li, Xinmin; Xu, Yuyan; Wang, Chunming; Zhong, Kaihang; Zhang, Cheng; Xie, Qingyu; Pan, MingxinAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
查看全部 →

会议信息

会议名称
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
会议日期
2023-06-02 至 2023-06-06
论文集名
JOURNAL OF CLINICAL ONCOLOGY
发表日期
2023-06-01
资助标注
Taizhou Hanzhong Biomedical Co., LTD.
收录
ISTP · SCIE

作者

  • Z

    Zhao, Hong (第一作者)

  • Z

    Zhou, Aiping

查看全部 15 位作者收起作者
  • T

    Tu, Jianfei

  • B

    Bai, Yuxian

  • M

    Mao, Xianhai

  • S

    Song, Tianqiang

  • L

    Li, Bo

  • D

    Dai, Wenxiang

  • L

    Lv, Jing

  • W

    Wang, Jufeng

  • C

    Che, Xu

  • L

    Liu, Lianxin

  • Z

    Zhang, Lianhai

  • W

    Wu, Wei

  • C

    Cai, Jianqiang

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417